We are live on
!
Find out more
First Manhattan Portfolio holdings
AUM
$36.1B
1-Year Est. Return
11.5%
This Fund
S&P 500
This Quarter
Est. Return
+12.39%
1 Year Est. Return
+11.5%
3 Year Est. Return
+74.65%
5 Year Est. Return
+103.66%
10 Year Est. Return
+354.63%
AUM
$19.4B
AUM Growth
+$2.11B
(+12%)
Cap. Flow
+$90.4M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
53.93%
Holding
1,534
New
81
Increased
246
Reduced
456
Closed
138
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$105M |
| 2 |
Match Group
MTCH
|
+$77.8M |
| 3 |
NextEra Energy
NEE
|
+$64.3M |
| 4 |
Keysight
KEYS
|
+$62.4M |
| 5 |
AutoZone
AZO
|
+$56.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$82.5M |
| 2 |
Microsoft
MSFT
|
+$42.5M |
| 3 |
Apple
AAPL
|
+$38.2M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$27M |
| 5 |
Johnson & Johnson
JNJ
|
+$22.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 38.9% |
| 2 | Technology | 17.9% |
| 3 | Healthcare | 11.08% |
| 4 | Communication Services | 8.12% |
| 5 | Consumer Discretionary | 7.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
TriMas Corp
TRS
$1.44B
| $17.3M | 0.09% |
759,973
+6,990
| +0.9% | +$170K |
|
102
FedEx
FDX
$75B
| $17.3M | 0.09% |
68,789
-26,373
| -28% | -$5.27M |
|
103
PepsiCo
PEP
$187B
| $17.2M | 0.09% |
123,921
-8,114
| -6% | -$1.1M |
|
104
Enanta Pharmaceuticals
ENTA
$373M
| $17.2M | 0.09% |
374,885
-19,312
| -5% | -$936K |
|
105
Howard Hughes
HHH
$3.95B
| $16.4M | 0.08% |
299,281
-27,288
| -8% | -$1.46M |
|
106
Brixmor Property Group
BRX
$9.94B
| $16.4M | 0.08% |
1,402,240
-57,925
| -4% | -$699K |
|
107
Cencora
COR
$60.1B
| $15.8M | 0.08% |
163,110
+13,206
| +9% | +$1.31M |
|
108
Vanguard S&P 500 ETF
VOO
$968B
| $15.7M | 0.08% |
51,171
-581
| -1% | -$177K |
|
109
Eli Lilly
LLY
$1.06T
| $15.6M | 0.08% |
105,405
+359
| +0.3% | +$55.6K |
|
110
Idexx Laboratories
IDXX
$43B
| $15.4M | 0.08% |
39,175
-1,611
| -4% | -$596K |
|
111
Wells Fargo
WFC
$261B
| $15.3M | 0.08% |
651,077
-14,820
| -2% | -$365K |
|
112
Mettler-Toledo International
MTD
$26.9B
| $15.3M | 0.08% |
15,794
-26
| -0.2% | -$24.1K |
|
|
HTO
113
H2O America
HTO
$2.68B
| $15.1M | 0.08% |
248,149
-1,000
| -0.4% | -$63.2K |
|
114
Air Products & Chemicals
APD
$66.2B
| $14.8M | 0.08% |
49,822
-4
| -0% | -$1.15K |
|
115
TE Connectivity
TEL
$58.4B
| $14.7M | 0.08% |
150,467
-2,839
| -2% | -$261K |
|
116
CBIZ
CBZ
$2.29B
| $14.6M | 0.08% |
639,884
+37,250
| +6% | +$885K |
|
117
Lennar Class A
LEN
$20.3B
| $14.5M | 0.07% |
183,198
-2,325
| -1% | -$165K |
|
118
Ascendis Pharma A/S
ASND
$16.7B
| $14.4M | 0.07% |
93,600
| – | – |
|
119
Merck
MRK
$324B
| $14.4M | 0.07% |
182,336
-5,161
| -3% | -$404K |
|
120
Colgate-Palmolive
CL
$72.3B
| $14.3M | 0.07% |
185,034
+3,000
| +2% | +$229K |
|
121
Cisco
CSCO
$448B
| $14.1M | 0.07% |
357,624
-838
| -0.2% | -$36.5K |
|
122
Zimmer Biomet
ZBH
$17.6B
| $14.1M | 0.07% |
169,488
-8,772
| -5% | -$1.15M |
|
123
Nutrien
NTR
$32.8B
| $14M | 0.07% |
357,273
-6,021
| -2% | -$219K |
|
124
Liberty Broadband Class A
LBRDA
$4.17B
| $13.7M | 0.07% |
96,818
+4,499
| +5% | +$610K |
|
125
Middlesex Water
MSEX
$1.05B
| $13.7M | 0.07% |
220,064
-1,008
| -0.5% | -$65.4K |
|
Similar funds
SAM
First Manhattan's Q3 2020 Portfolio in Review
As of Q3 2020, First Manhattan held 1,534 positions worth $19.4B, up 12% from $17.3B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
First Manhattan's Q3 2020 filing shows 81 new, 246 increased, 456 reduced and 138 closed positions. Its largest new stake was Constellation Pharmaceuticals, Inc.: 250,400 shares worth $5.07M. The largest sale was People Inc, an estimated $82.5M.
By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 38% a quarter earlier, followed by Technology and Healthcare.
- First Manhattan's largest Q3 2020 buy was Constellation Pharmaceuticals, Inc.: 250,400 shares worth $5.07M.
- First Manhattan added most to UnitedHealth in Q3 2020, an estimated $105M increase.
- First Manhattan's biggest Q3 2020 reduction was People Inc, cutting an estimated $82.5M.
- First Manhattan fully exited Aimmune Therapeutics in Q3 2020, selling an estimated $17.1M.
- First Manhattan's ten largest holdings make up 54% of its $19.4B portfolio in Q3 2020.
- First Manhattan opened 81 new positions and closed 138 in Q3 2020.
- First Manhattan's portfolio value rose 12% quarter-over-quarter to $19.4B.
Based on First Manhattan's 13F filing for Q3 2020, filed 12 Nov 2020.